<DOC>
<DOCNO>
EP-0011435
</DOCNO>
<TEXT>
<DATE>
19800528
</DATE>
<IPC-CLASSIFICATIONS>
A61K-38/21 C07K-14/555 C07K-14/435 C07K-14/52 C07K-1/00 C07K-14/565 C12P-21/00 <main>C07G-7/00</main> C07K-1/22 A61K-45/02 
</IPC-CLASSIFICATIONS>
<TITLE>
method of purification of human fibroblast interferon.
</TITLE>
<APPLICANT>
toray industriesjp<sep>toray industries, inc. <sep>toray industries, inc.2, nihonbashi-muromachi 2-chome chuo-kutokyo 103 jp  <sep>toray industries, inc.<sep>
</APPLICANT>
<INVENTOR>
hosoi kazuo<sep>ozawa hitoshi<sep>hosoi, kazuo<sep>ozawa, hitoshi<sep>hosoi, kazuo1-17, 2-chome, tsunishikamakura-shi, kanagawa-kenjp<sep>ozawa, hitoshi547-12, sanadahiratsuka-shi, kanagawa-kenjp<sep>hosoi, kazuo  <sep>ozawa, hitoshi<sep>hosoi, kazuo1-17, 2-chome, tsunishikamakura-shi, kanagawa-kenjp<sep>ozawa, hitoshi547-12, sanadahiratsuka-shi, kanagawa-kenjp<sep>
</INVENTOR>
<ABSTRACT>
a method for the purification of human fibroblast interfe­ ron by the successive treatments of a crude interferon solu­ tion with a strongly acidic ion exchanger and a chelating  carrier which contains a chelating residue chelated with at  least one metal ion selected from the group consisting of  co⁺⁺, ni⁺⁺, zn⁺⁺, and cu⁺⁺.  
</ABSTRACT>
</TEXT>
</DOC>
